Indaptus Therapeutics, Inc. (INDP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.01M | -3.19M | -3.05M | -4.02M | -5.05M | -3.4M | -2.51M | -2.48M | -3.94M | -2.6M | -3.73M | -2.11M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -38.89% | 6.04% | -21.55% | -62.16% | -28.21% | -30.51% | 32.71% | -17.62% | 20.67% | -17.69% | 18.84% | 33.08% |
| Net Income | -2.54M | -8.11M | -2.98M | -5.23M | -4.53M | -4.13M | -3.07M | -4.02M | -3.81M | -4M | -3.92M | -3.25M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 735 | 320 | 321 | 322 |
| Stock-Based Compensation | 227.18K | 785.81K | 0 | 180.76K | 240.89K | 304.12K | 444.18K | 782.85K | 774.69K | 745.52K | 764.8K | 728.47K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 567.27K |
| Other Non-Cash Items | 410.15K | -241.34K | 55.02K | 787.7K | 0 | 0 | 0 | 0 | 0 | 0 | -140.57K | -728.47K |
| Working Capital Changes | -5.11M | 4.38M | -134.55K | 242.26K | -755.59K | 431.18K | 111.82K | 754.46K | -905.21K | 654.99K | -436.56K | 570.72K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.23M | 4.16M | 206.91K | -571.69K | -762.34K | 1.15M | 173.67K | 390K | -1.24M | 408.26K | 261.44K | 280K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7M | 8M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -106.02K | -110.23K |
| Cash from Financing | 0 | 5.87M | 2.72M | 6.28M | 3.15M | 1.8M | 2.59M | 38.06K | 316.05K | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 85.49K | 233.28K | 5.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 6.32M | 2.49M | 588.01K | 3.15M | 2.14M | 3M | 39.54K | 336.04K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -530.47K | 0 | -45.5K | 0 | -333.19K | -408.04K | -1.48K | -20K | 0 | 0 | 0 |
| Net Change in Cash | -7.01M | 2.68M | -332.06K | 2.27M | -1.9M | -1.59M | 78.94K | -2.44M | -3.62M | -2.6M | 3.27M | 5.89M |
| Free Cash Flow | -7.01M | -3.19M | -3.05M | -4.02M | -5.05M | -3.4M | -2.51M | -2.48M | -3.94M | -2.6M | -3.73M | -2.11M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -38.89% | 6.04% | -21.55% | -62.16% | -28.21% | -30.51% | 32.71% | -17.62% | 20.67% | -17.48% | 42.89% | 33.08% |
| FCF per Share | -3.23 | -1.47 | -0.53 | -0.70 | -0.54 | -0.36 | -0.26 | -0.29 | -0.47 | -0.31 | -0.44 | -0.25 |
| FCF Conversion (FCF/Net Income) | 2.76x | 0.39x | 1.03x | 0.77x | 1.11x | 0.82x | 0.82x | 0.62x | 1.03x | 0.65x | 0.95x | 0.65x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |